Fate Therapeutics Inc. buy BiotechBee
Start price
26.10.22
/
70%
€20.67
Target price
31.12.24
€35.00
Performance (%)
-41.33%
End price
21.12.22
€12.12
Summary
This prediction ended on 21.12.22 with a price of €12.12. Massive losses of -41.33% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Fate Therapeutics Inc. | -7.508% | -7.508% | 59.830% |
iShares Core DAX® | 3.523% | 3.763% | 26.705% |
iShares Nasdaq 100 | 1.026% | 2.380% | 29.587% |
iShares Nikkei 225® | -0.063% | 0.000% | 15.214% |
iShares S&P 500 | 0.557% | 2.222% | 27.662% |
According to BiotechBee what are the pros and cons of Fate Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Buy mit Kursziel 35,0
In the thread Trading Fate Therapeutics Inc.
Buy beendet